Burgess M - Search Results

1

Method for the synthesis of multi-epitopic Streptococcus pyogenes lipopeptide vaccines using native chemical ligation.

Moyle PM, Olive C, Ho MF, Burgess M, Karpati L, Good MF, Toth I. Moyle PM, et al. Among authors: burgess m. J Org Chem. 2006 Sep 1;71(18):6846-50. doi: 10.1021/jo060960p. J Org Chem. 2006. PMID: 16930036

2

Vaginal delivery of siRNA using a novel PEGylated lipoplex-entrapped alginate scaffold system.

Wu SY, Chang HI, Burgess M, McMillan NA. Wu SY, et al. Among authors: burgess m. J Control Release. 2011 Nov 7;155(3):418-26. doi: 10.1016/j.jconrel.2011.02.002. Epub 2011 Feb 18. J Control Release. 2011. PMID: 21315117

3

Dendrosome-based delivery of siRNA against E6 and E7 oncogenes in cervical cancer.

Dutta T, Burgess M, McMillan NA, Parekh HS. Dutta T, et al. Among authors: burgess m. Nanomedicine. 2010 Jun;6(3):463-70. doi: 10.1016/j.nano.2009.12.001. Epub 2010 Jan 4. Nanomedicine. 2010. PMID: 20044033

4

Self-catalyzed degradable cationic polymer for release of DNA.

Truong NP, Jia Z, Burgess M, Payne L, McMillan NA, Monteiro MJ. Truong NP, et al. Among authors: burgess m. Biomacromolecules. 2011 Oct 10;12(10):3540-8. doi: 10.1021/bm2007423. Epub 2011 Aug 31. Biomacromolecules. 2011. PMID: 21838265

5

Systemic delivery of E6/7 siRNA using novel lipidic particles and its application with cisplatin in cervical cancer mouse models.

Wu SY, Singhania A, Burgess M, Putral LN, Kirkpatrick C, Davies NM, McMillan NA. Wu SY, et al. Among authors: burgess m. Gene Ther. 2011 Jan;18(1):14-22. doi: 10.1038/gt.2010.113. Epub 2010 Aug 12. Gene Ther. 2011. PMID: 20703312

6

Inhibition of cervical cancer cell growth in vitro and in vivo with dual shRNAs.

Gu W, Payne E, Sun S, Burgess M, McMillan NA. Gu W, et al. Among authors: burgess m. Cancer Gene Ther. 2011 Mar;18(3):219-27. doi: 10.1038/cgt.2010.72. Epub 2010 Nov 19. Cancer Gene Ther. 2011. PMID: 21102424

7

Efficient Biodistribution and Gene Silencing in the Lung epithelium via Intravenous Liposomal Delivery of siRNA.

McCaskill J, Singhania R, Burgess M, Allavena R, Wu S, Blumenthal A, McMillan NA. McCaskill J, et al. Among authors: burgess m. Mol Ther Nucleic Acids. 2013 Jun 4;2(6):e96. doi: 10.1038/mtna.2013.22. Mol Ther Nucleic Acids. 2013. PMID: 23736774 Free PMC article.

8

CCL2 and CXCL2 enhance survival of primary chronic lymphocytic leukemia cells in vitro.

Burgess M, Cheung C, Chambers L, Ravindranath K, Minhas G, Knop L, Mollee P, McMillan NA, Gill D. Burgess M, et al. Leuk Lymphoma. 2012 Oct;53(10):1988-98. doi: 10.3109/10428194.2012.672735. Epub 2012 Apr 19. Leuk Lymphoma. 2012. PMID: 22397722

9

CD62L as a therapeutic target in chronic lymphocytic leukemia.

Burgess M, Gill D, Singhania R, Cheung C, Chambers L, Renyolds BA, Smith L, Mollee P, Saunders N, McMillan NA. Burgess M, et al. Clin Cancer Res. 2013 Oct 15;19(20):5675-85. doi: 10.1158/1078-0432.CCR-13-1037. Epub 2013 Aug 15. Clin Cancer Res. 2013. PMID: 23948971

10

High serum levels of CD178 (soluble FasL) predict for inferior progression free survival in chronic lymphocytic leukemia treated with fludarabine-based chemotherapy.

Tate C, Burgess M, McMillan NA, Saunders NA, Cheung C, Gill D, Mollee P. Tate C, et al. Among authors: burgess m. Leuk Lymphoma. 2019 Oct;60(10):2563-2567. doi: 10.1080/10428194.2019.1581936. Epub 2019 Jun 25. Leuk Lymphoma. 2019. PMID: 31237178 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

966 results

Search Page

Filters